• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
SUN Zhuolin, LIU Jingwei, KUANG Changchun. Inhibitions and mechanisms of amygdalin in non-small cell lung cancer NCI-H1299 cell line invasion in vitro[J]. Journal of China Pharmaceutical University, 2016, 47(4): 479-482. DOI: 10.11665/j.issn.1000-5048.20160415
Citation: SUN Zhuolin, LIU Jingwei, KUANG Changchun. Inhibitions and mechanisms of amygdalin in non-small cell lung cancer NCI-H1299 cell line invasion in vitro[J]. Journal of China Pharmaceutical University, 2016, 47(4): 479-482. DOI: 10.11665/j.issn.1000-5048.20160415
shu

Inhibitions and mechanisms of amygdalin in non-small cell lung cancer NCI-H1299 cell line invasion in vitro

More Information
    Graphical Abstract
    • Abstract
  • The aim of this study was to investigate the effects and mechanisms of a nature product, amygdalin, in non-small cell lung cancer NCI-H1299 cell line invasion and migration in vitro. NCI-H1299(H1299)cells were treated with amygdalin. MTS assay was employed to determine cell proliferation, transwell chamber and wound-healing assay were employed to determine invasion and migration in vitro, western blotting and RT-PCR assay were employed to determine the expression of integrin β1, integrin β4, integrin-linked kinase(ILK), focal adhesion kinase(FAK), p-FAK and β-catenin, and the phosphorylation of Akt and RICTOR. Results showed that in vitro proliferation of H1299 cells were inhibited significantly after treated with 0. 5 and 1 mg/mL amygdalin for 48 h. The invasion and migration potential was decreased. The protein and mRNA expression of MMP-2/9, integrin β1/4, ILK, FAK, β-catenin, the activity of MMP-2/9, the phosphorylation of FAK, Akt and RICTOR were all decreased significantly(all of P< 0. 05).
    • FullText(HTML)
    • References (10)
  • [1]
    Reck M,Popat S,Reinmuth N,et al.Metastatic non-small-cell lung cancer(NSCLC):ESMO clinical practice guidelines for diagnosis,treatment and follow-up[J].Ann Oncol,2014,25(Suppl 3):iii27-39.
    [2]
    Bolarinwa IF,Orfila C,Morgan MR.Amygdalin content of seeds,kernels and food products commercially-available in the UK[J].Food Chemistry,2014,152:133-139.
    [3]
    Makarevi 'c J,Rutz J,Juengel E,et al.Amygdalin blocks bladder cancer cell growth in vitro by diminishing cyclin A and cdk2[J].PLoS One,2014,9(8):e105590.
    [4]
    Niu G,Ye T,Qin L,et al.Orphan nuclear receptor TR3/Nur77 improves wound healing by upregulating the expression of integrin β4[J].FASEB J,2015,29(1):131-140.
    [5]
    Matsubara D,Kishaba Y,Yoshimoto T,et al.Immunohistochemical analysis of the expression of E-cadherin and ZEB1 in non-small cell lung cancer[J].Pathol Int,2014,64(11):560-568.
    [6]
    Song JL,Nigam P,Tektas SS,et al.MicroRNA regulation of Wnt signaling pathways in development and disease[J].Cell Signal,2015,27(7):1380-1391.
    [7]
    Sulzmaier FJ,Jean C,Schlaepfer DD.FAK in cancer:mechanistic findings and clinical applications[J].Nat Rev Cancer,2014,14(9):598-610.
    [8]
    Fumarola C,Bonelli MA,Petronini PG,et al.Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer[J].Biochem Pharmacol,2014,90(3):197-207.
    [9]
    Calderaro J,Rebouissou S,de Koning L,et al.PI3K/AKT pathway activation in bladder carcinogenesis[J].Int J Cancer,2014,134(8):1776-1784.
    [10]
    Liu Y,Wang TT,Chen L.Synthesis and antitumor activity of isosteviol derivatives[J].J China Pharm Univ(中国药科大学学报),2016,47(1):48-53.
    • Related Articles

  • Related Articles

    [1]LI Zhenming, HUO Meirong, DENG Qidan, CHEN Dengjun, SUN Hongzhang. In vitro evaluation of saxagliptin and metformin hydrochloride sustained-release tablets[J]. Journal of China Pharmaceutical University, 2021, 52(5): 541-546. DOI: 10.11665/j.issn.1000-5048.20210505
    [2]ZHANG Jinlin, YUAN Yaozuo, ZHANG Ya, ZHAO Shuqiang, ZHAO Xun, ZHANG Mei. Consistency evaluation of domestic generic rifampicin capsules and reference drug in vitro[J]. Journal of China Pharmaceutical University, 2018, 49(5): 603-609. DOI: 10.11665/j.issn.1000-5048.20180513
    [3]Study on Optimize the Preparation and Formulation of Nimodipine-Containing Nanoliposome[J]. Journal of China Pharmaceutical University, 2003, (1): 27-30.
    [4]Distribution of Nimodipine Microemulsion in Mice In vivo and Evaluation on Its Targeting Performance[J]. Journal of China Pharmaceutical University, 2002, (4): 31-34.
    [5]Study on Transdermal Therapeutic System for Nimodipine[J]. Journal of China Pharmaceutical University, 2000, (5): 28-31.
    [6]Development of Nimodipine Sustained Release Capsules[J]. Journal of China Pharmaceutical University, 1999, (5): 346-349.
    [7]The Factors Influencing Nimodipine Release from Hydroxypropyl Methylcellulose Matrix Tablet[J]. Journal of China Pharmaceutical University, 1998, (6): 418-421.
    [8]Improved Process of Nimodipine[J]. Journal of China Pharmaceutical University, 1998, (3): 82-83.
    [9]Study on Penetration Enhancers for Nimodipine[J]. Journal of China Pharmaceutical University, 1994, (3): 149-152.
    [10]CORRELATION BETWEEN THE ABSORPTION IN VIVO AND THE RELEASE IN VITRO OF TWO CONTROLLED-RELEASE TABLETS OF AMINOPHYLLINE[J]. Journal of China Pharmaceutical University, 1986, (1): 18-23.

Catalog

    Get Citation
    PDF
    XML
    Article views PDF downloads Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return